Short version of what the eligibility process actually involved for my family member: a full blood count, kidney and liver function tests, inflammatory markers including CRP and ESR, an HbA1c because of borderline glucose readings in a previous test, chest imaging, a review of all current medications cross-checked against known interaction profiles with MSC therapy, a physical examination, and a detailed intake interview covering symptom history and previous treatment attempts. That was just the first stage. If anything in stage one raised a question, a second stage of condition-specific testing followed. In this case it did there was a query about thyroid function that prompted an additional panel before the eligibility decision was finalised. It wasn’t quick, but it was thorough.
My uncle was considering stem cell therapy for his joint pain, and we visited a hospital in Seoul based on a recommendation from a friend. Before anything began, the medical team conducted a very thorough evaluation, including blood tests, imaging scans, and a detailed consultation. It wasn’t just about approving treatment they carefully assessed whether his condition, overall health, and medical history made him a suitable candidate.
The doctors also explained that not every patient qualifies for stem cell therapy, as strict screening guidelines are followed to ensure safety and effectiveness. We really appreciated how clearly they explained each step of the process and the available options. Overall, the approach felt very structured, safe, and tailored to his individual needs, which gave us a lot of confidence moving forward.
The evaluation process is actually quite thorough. Patients first go through a consultation where symptoms and goals are discussed. After that, diagnostic tests are ordered depending on the condition this might include blood tests, hormone analysis, autoimmune screening, or imaging scans. Everything is reviewed together to determine whether stem cell therapy is appropriate or if other treatments should be prioritized first.
When my grandfather decided to try stem cell therapy in Korea, he was really impressed by how carefully the medical team handled everything. They took time to review his full medical history and carried out the necessary tests to ensure the treatment would be safe and appropriate for him. Each step of the process was explained clearly, which helped him feel confident and reassured throughout.
He also appreciated that the treatment plan was tailored specifically to his health condition rather than being a general approach. Overall, he felt well cared for and understood during the entire experience, which left him with a positive impression of the structured and patient-focused care he received.
Hello, When my father went for stem cell therapy the clinic made sure to carefully check his health before starting. They reviewed his medical history and asked about past treatments and current medications. He also had to do blood tests and some imaging so the doctors could be sure the therapy would be safe and effective for him. The process felt very professional and gave us peace of mind that nothing was rushed. Based on his experience I would recommend Browneye Medical Clinic with Dr Hansen Lee.
What surprised me most about MiraeCell Clinic eligibility assessment was the personalized care. They didn’t treat me like just another case; they genuinely listened to my symptoms and concerns during the initial consultation. The required tests felt targeted, not just a generic battery, which was reassuring.
Before starting stem cell therapy, clinics usually perform a full-body assessment depending on the case. Blood work is almost always required to check overall health, infection markers, and organ function. Imaging like MRI or ultrasound is often used for musculoskeletal or neurological conditions. They also carefully review medical history to avoid complications. If the patient is not a good candidate, they typically recommend alternative treatment plans.
What the assessment revealed, more than anything else, was how much context matters in this space. Two people with the same diagnosis on their medical records can have completely different eligibility outcomes depending on disease stage, current inflammatory burden, organ function, medication history, and how long they’ve been symptomatic. The physician reviewing the case was explicit about this eligibility isn’t determined by diagnosis alone, it’s determined by the full clinical picture at the specific moment of assessment. That meant the answer given to one patient with the same condition wasn’t necessarily predictive of what the answer would be for another. It sounds obvious when you say it out loud, but plenty of patient forums talk about eligibility as though it’s condition-specific rather than person specific. It isn’t.
韓国で幹細胞治療の相談に行きました。血液検査と健康チェックを受け、治療の適応があるか確認しました。スタッフは丁寧で、過去の患者さんの写真も見せてくれました。
One thing the eligibility process made clear was that previous treatment history matters enormously. Specifically, whether you’ve been on immunosuppressants, how recently, and at what dose. The assessment team spent considerable time on this part of the intake because certain immunosuppressive medications need to be cleared from the system before cell therapy is appropriate, and the washout period varies significantly by drug. For someone who’d been on a particular biologic for two years, the clearance timeline was longer than expected, which pushed the treatment date back by several weeks. The eligibility wasn’t denied it was conditionally approved pending that washout period. Understanding that distinction upfront would have saved considerable anxiety about what the delay actually meant.
Eligibility isn’t automatic it depends on multiple medical factors. The process usually begins with reviewing previous diagnoses and ongoing medications. Then comes a set of diagnostic tests such as blood panels, inflammation markers, and sometimes genetic or immune testing depending on the condition. Imaging scans are also commonly used. All these results help determine whether stem cell therapy is safe and potentially beneficial.
My aunt was considering stem cell therapy for her knee osteoarthritis, and we visited a clinic in Seoul. The process began with a detailed consultation where the medical team reviewed her medical history and current symptoms in depth. Before proceeding with any treatment, they conducted several diagnostic tests, including blood work, MRI scans, and joint mobility assessments, to determine whether she was a suitable candidate.
The doctors also explained that not every patient qualifies for stem cell therapy, especially if there are underlying health conditions or if the joint damage is too advanced. They were very transparent about the entire evaluation and treatment process, which helped us feel more informed and confident. Eventually, she began treatment under medical supervision, and over time she experienced reduced pain and improved mobility, which made a noticeable difference in her daily life.
The psychological assessment component was brief but present, and I think it deserves more attention than it typically gets in conversations about stem cell eligibility. It wasn’t a formal psychiatric evaluation more a structured conversation about expectations, understanding of the experimental nature of the treatment, and readiness to engage with the post-treatment monitoring requirements. The reasoning was practical: patients who don’t understand that this isn’t a guaranteed cure tend to disengage from follow-up protocols when early results are ambiguous, which compromises the quality of the outcome data and potentially their own ongoing care. Informed, realistic expectations aren’t just ethically important they’re clinically relevant to how the treatment process unfolds.
From what I understand, clinics follow a structured screening protocol before approving stem cell therapy. It includes consultation, detailed medical history review, lab investigations, and imaging studies. These tests help assess whether the patient’s condition is stable enough and whether regenerative therapy can realistically provide improvement. If risk factors are detected, they may adjust or postpone treatment.
The eligibility assessment is very individualized. Some patients may only need basic blood work, while others require extensive testing like MRI scans, metabolic panels, or autoimmune screening. The purpose is to understand the severity of the condition and ensure the body can safely respond to stem cell treatment. It’s not offered casually, it goes through multiple medical checkpoints.
Usually, the first step is a detailed consultation where symptoms and medical history are discussed. After that, doctors order specific tests depending on the condition. Blood tests are standard, but imaging like CT or MRI may be added for deeper evaluation. The results are analyzed collectively to decide if stem cell therapy is suitable or if other treatments should be considered first.
The overall process is very methodical. It starts with consultation, followed by detailed testing such as blood panels and imaging scans. Doctors then review all results together to understand whether stem cell therapy is safe and appropriate. If risks are detected, they usually modify the plan or recommend alternative treatments instead of proceeding directly.
Before starting treatment, patients usually go through a full diagnostic workup. This can include blood tests, scans, and sometimes specialized tests depending on the disease. Doctors also evaluate how the condition has progressed over time. Only after reviewing all data do they confirm eligibility for stem cell therapy.
Age came up during the assessment in a way I hadn’t expected not as a disqualifying factor, but as a variable that shaped the protocol design. Bone marrow yield and cell viability decline with age, which affects both source selection and concentration decisions. For older patients, the assessment includes an additional evaluation of autologous cell quality before determining whether a purely autologous approach is viable or whether an allogeneic component needs to supplement it. The eligibility process for a 68 year old is therefore structurally different from the same process for someone in their forties, even if the diagnosis is identical. Knowing that going in helps set realistic expectations about what the assessment will involve and why.
The screening process typically involves multiple steps. First comes history-taking, then laboratory testing such as blood count, metabolic health, and inflammation levels. Imaging tests are also commonly used to evaluate structural damage. All findings are reviewed together to assess whether the patient is a suitable candidate for stem cell therapy.